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The duration of ejaculatory suppression of alpha adrenoceptor antagonist (tamsulosin, TAM) was
investigated in goats. Five males were injected intramuscularly with TAM 80 mg/kg (179.8 nmol/kg).
Semenwas collected using an artiﬁcial vagina with estrous female goats and the semen quality and libido
score were evaluated at 1, 3, 6 and 9 h post TAM injection. Two replicates were carried out in the study.
Heart rates were also measured before the injection and at 30 min before semen collection. The results
showed that the libido score was not affected by TAM. At 1 h post injection, the highest percentage of
suppressed ejaculation (80%) was recorded and this effect was maintained for up to 3 h post injection
(60%). Thereafter the percentage of suppressed ejaculation was signiﬁcantly decreased (p < 0.05) at 6 h
(20%) and ejaculation was completely recovered at 9 h post injection. The semen characteristics of the
collectable semen, semen volume and number of spermatozoa were lowest at 1 h and 3 h, thereafter they
suddenly increased at 6 h and the signiﬁcantly highest peak was noted at 9 h post injection. TAM in-
jection suppressed goat ejaculation within 1 h and the duration was maintained up to 3 h post injection.
Copyright © 2016, Kasetsart University. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Male temporary contraception during a speciﬁc period is occa-
sionally required in some animal species, especially in some species
of wildlife or feral animals that can multiply rapidly (Malik et al.,
1984; Hughes and Macdonald, 2013; Bassi et al., 2015). Male per-
manent contraception is difﬁcult and expensive (Murray et al.,
2015; Zapata-Rios and Branch, 2016). Moreover, this procedure
must be performed on the dominant male of the herd and so the
best genetic information may be eliminated from the population
andmaintaining the sexual desire in the dominantmale has beneﬁt
in preventing repeat copulation from other males in some species
(Hynes et al., 2005; Surbeck et al., 2011).
The inhibition of the ejaculation process would be useful for this
purpose. Alpha adrenoceptor antagonist is used as a treatment forin).
versity.
Production and hosting by Elsevlower tract symptoms caused by benign prostatic hyperplasia and
one of the drugs in this group, tamsulosin (TAM) has been reported
to have a side effect on ejaculatory dysfunction or ejaculation dis-
order (Schulman, 2001; Giuliano et al., 2006; Hellstrom and Sikka,
2006b, Hellstrom et al., 2009; Hisasue et al., 2006). Oral adminis-
tration of TAM (0.8 mg) signiﬁcantly reduced the semen volume
compared to a placebo in human volunteers (Hellstrom and Sikka,
2006b). A negative role in the expulsion phase of ejaculation has
been observed after intravenous injection of TAM (1 mg/kg) in rats
(Giuliano et al., 2006). The effects of TAM on the temporary sup-
pression of goat ejaculation without changing sexual desire and
physiological characteristics have been reported by the current
researchers (Kimsakulvech et al., 2014).
To facilitate contraception usage of alpha1 adrenoceptor
antagonist, knowledge of its onset and duration effects are neces-
sary. In humans, some previous studies obtained ejaculatory
dysfunction only once after some consecutive days of TAM
administration (0.4 mg) while the ejaculatory volume recovered at
3 d following TAM withdrawal (Giuliano et al., 2006; Hisasue et al.,
2006; Hellstrom et al., 2009). Previously, TAM has been shown toier B.V. This is an open access article under the CC BY-NC-ND license (http://
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eliminated within 24 h (Kimsakulvech et al., 2014). Interestingly,
TAM has been reported to decrease the blood pressure from a
baseline in humans with oral administration of 0.4 mg TAM
decreasing the systolic and diastolic blood pressure from a baseline
during 2e10 h and causing an increased pulse rate from a baseline
during 2e6 h after administration (Michel et al., 2005b). In dogs,
intravenous administration of TAM at 3 mg/kg had a maximal effect
on decreasing the mean arterial blood pressure within 30 min
(Ohtake et al., 2004).
However, effective duration of suppressed ejaculation still re-
mains unavailable. Therefore, the present study aimed to clarify the
ejaculatory suppression effect of TAM in goats, in terms of the onset
and effective duration. Male goats have distinct characteristic of a
high libido which may suit testing for suppression of the sexual
process. Very little information on the effects of TAM in this species
is currently available. This study thus investigated the effect of TAM
on the sexual interest, characteristics of ejaculation and semen
quality in goats.
Materials and methods
Animals and treatment
Experiment procedures was approved by the Animal Usage and
Ethics Committee, Kasetsart University (ID no. ACKU 02156). Five
mixed-breed, male goats aged 1e3 yr and weighing 27e65 kg were
selected from a private farm. On the farm, the male goats had been
kept together in a pen separated from female goats. All male goats
studied were evaluated and conﬁrmed to have good libido, were
able to serve an artiﬁcial vagina (AV) and had normal semen quality.
Attempts at semen collection using AV with an estrous female at
1 h, 3 h, 6 h and 9 h post intramuscular injection of TAM (80 mg/kg)
were carried out. Two replicates, a week apart, were carried out in
the study.
Soluble preparation
Tamsulosin hydrochloride and dimethyl sulfoxide (DMSO) were
purchased from SigmaeAldrich Pte Ltd. For ease of injection, TAM
was diluted with DMSO to gain the amount required for each goat.
Libido scoring and semen collection
Each goat had chances to serve the AV at least once within
10e20 min in the designated periods. In the ﬁrst attempt, if no
ejaculated semen was found in the AV collecting tube after
thrusting, the anejaculate male was allowed to have a second
attempt within 10 min. Sexual interest was recorded using the
method of Frydrychova et al. (2011) and recorded for libido.
Ejaculatory characteristics
The ejaculation response in this studywas classiﬁed as complete
ejaculation or suppressed ejaculation. Ejaculation with spermato-
zoa having a volume of 0.1 mL or more was classiﬁed as complete
ejaculation and no ejaculated semen or a volume less than 0.1 mL
was classiﬁed as suppressed ejaculation.
Semen quality assessment
The semen attributes in this study were: the semen volume,
mass spermatozoa movement score, percentage of motile and live
spermatozoa, sperm concentration, number of spermatozoa per
ejaculate and seminal alkaline phosphatase (ALP). Semen on the AVcone and collecting tube was collected and included in the semen
volume measurement. The semen volume was measured with the
aid of automatic pipettes. The mass spermatozoa movement score
ranging from 0 (immotile) to 5 (high) and the percentage of motile
spermatozoa were evaluated under a light microscope. The sperm
concentration was estimated using a hemocytometer. Semen was
diluted 400 fold with hypo-osmotic swelling solution and the
percentage of live spermatozoa was evaluated (Revell and Mrode,
1994). Seminal alkaline phosphatase (ALP) was analyzed using
the Reﬂotron® dry chemistry method (Roche Boehringer; Man-
nheim, Germany).
Heart rate measurement
The heart rate was measured in beats per minute (bpm) at
30 min before the treatment injection and before collecting semen
for all time periods in the study.
Statistical analysis
The numbers of suppressed ejaculations in each time period
were compared using Pearson’s c2 test. Libido scores were exam-
ined using the Friedman test and Wilcoxon test. Mean values were
considered statistically different at p < 0.05 ANOVA using the
repeated measurement model procedure was applied for contin-
uous complete ejaculation, semen volume, percentages of motile
and live spermatozoa, sperm concentration, number of spermato-
zoa and ALP between times. Heart rate data were analyzed using
ANOVA and the general linear model procedure. All values except
the numbers of ejaculation were presented as the mean and stan-
dard error of mean (SEM). Statistical analysis was performed using
the SPSS package (SPSS Inc.; Chicago, IL, USA).
Results
Effect on libido
In total, 10 attempts at semen collection were carried out for
each designated period. There were no differences in the libido
scores among the periods as shown in Table 1.
Effect on ejaculation
The number of suppressed ejaculations after TAM injection is
shown in Table 1. It was found that number of suppressed ejacu-
lations at 1 h (8, 80%) was not signiﬁcantly different from that at 3 h
(6, 60%) but that at 1 hwas signiﬁcantly higher (p< 0.05) than those
of 6 h and 9 h. At 3 h, the number of suppressed ejaculations was
signiﬁcantly higher than at 9 h. It then signiﬁcantly decreased at 6 h
(2, 20%) and all goats had complete ejaculation at 9 h post injection.
Effect on semen quality
The semen volume increased with time, being the lowest at 1 h
and 3 h; thereafter, it suddenly increased at 6 h and was highest at
9 h (Table 2). The numbers of spermatozoa were lowest at 1 h and
3 h; thereafter, they increased andwere highest at 9 h. On the other
hand, the mean percentage of live spermatozoa was highest at 1 h,
after which, it abruptly decreased at 3 h and was lowest at 6 h and
9 h.
The continuity of complete ejaculation for each goat was
calculated each time. Only three goats had complete ejaculation at
3 h, 6 h and 9 h post injection and the semen quality of these goats
is shown in Table 2. The semen volume at 3 h showed signiﬁcantly
lower values (p < 0.05) than those at 6 h and 9 h. The number of
Table 1
Libido score (mean ± SE), percentage of suppressed ejaculation and heart rate
(mean ± SE) at 0e9 h of tamsulosin injection (80 mg/kg).
Time (h) n Libido score Suppressed
ejaculations (%)
Heart rate
(beats/min)
0 10 e e 85.80 ± 6.40
1 10 4.80 ± 0.20 8 (80)a* 109.40 ± 10.74
3 10 4.80 ± 0.20 6 (60)ab 104.40 ± 9.13
6 10 5.00 2 (20)b 103.80 ± 8.76
9 10 5.00 0 (0)c 105.0 ± 5.94
*Values with different lowercase superscripts in the same column are signiﬁcantly
different at p < 0.05.
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Therewas no time effect onmotile spermatozoa, mass spermatozoa
movement, sperm concentration, percentage of live spermatozoa
and ALP.
Effect on heart rate
The heart rate prior to TAM injection was 85.80 ± 6.40 bpm
before injection and suddenly increased at 1 h
(109.40 ± 10.74 bpm); thereafter, it slightly decreased but sustained
a high rate until 9 h post injection (Table 1).
Discussion
This study demonstrated that TAM can suppress goat ejacula-
tion at 1 h post injection and the duration of ejaculatory suppres-
sionwasmaintained for up to 3 h post injection. TAMmay also have
affected the semen quality in terms of the semen volume and
number of spermatozoa.
Sexual desire after TAM treatment was not diminished even
though each goat had several copulations per day post TAM in-
jection. These results conﬁrmed evidence that TAM at a dosage of
80 mg/kg did not affect sexual desire in goats (Kimsakulvech et al.,
2014).
Previous studies had shown an ejaculatory dysfunction effect of
alpha1 adrenoceptor antagonist. However, the onset and period of
this chemical were not determined (Kedia and Persky, 1981;
Schulman, 2001; Andersson and Wyllie, 2003; Hisasue et al.,
2006; Hellstrom and Sikka, 2006a, 2006b). The present study
demonstrated that TAM at 80 mg/kg resulted in a high percentage of
suppressed ejaculations at 1 h post injection and the effect was
maintained for 3 h post injection. Therefore, this study clariﬁed the
temporary ejaculatory suppression effect of TAM in goats.
The mechanism of TAM-induced ejaculatory suppress action is
not well documented in goat. A possible mechanism has been
proposed previously in humans, where it has been suggested that
TAM may suppress ejaculation through an afﬁnity of 5-
hydroxytryptamine 1A (5HT1A) and Dopamine2 (D2)-likeTable 2
Semen quality and seminal alkaline phosphatase (mean ± SE) at 1e9 h post tamsulosin
Time
(h)
n Semen volume
(mL)
Motile
spermatozoa (%)
Mass spermatozoa
movement score
Spermato
(109 cell
0 2 0.24 ± 0.04 97.50 ± 2.50 5.00 5.90 ± 0.7
1 4 0.21 ± 0.06 82.50 ± 10.89 4.50 ± 0.50 3.77 ± 0.3
3 8 0.60 ± 0.12 85.63 ± 3.05 4.63 ± 0.18 3.79 ± 0.5
6 10 0.73 ± 0.11 81.00 ± 3.71 4.40 ± 0.26 4.15 ± 0.6
Continuous complete ejaculation at 3, 6 and 9 h post tamsulosin injection
3 3 0.25 ± 0.08ay 78.33 ± 14.24 4.33 ± 0.66 3.51 ± 0.4
6 3 0.67 ± 0.16b 80.00 ± 5.77 4.33 ± 0.33 3.46 ± 0.8
9 3 0.73 ± 0.06b 75.00 ± 10.41 4.10 ± 0.60 3.20 ± 0.6
*International units.
yValues with different lowercase superscripts in the same column are signiﬁcantly differreceptors in the central command of ejaculation (Andersson and
Wyllie, 2003; Giuliano et al., 2006). This may result in relaxation
of the urethral smooth muscle, decreasing the seminal vesicle,
reducing bulbospongiosus muscle contraction and resulting in
ejaculatory suppression (Giuliano et al., 2004, 2006; Ohtake et al.,
2006; Kobayashi et al., 2009) This mechanism might also be
involved in the suppression of goat ejaculation.
In humans, TAM at 0.4 mg once a day for 3 d resulted in ejac-
ulatory disorder at the third day. The semen volume recovered at
3 d following TAMwithdrawal (Hisasue et al., 2006). In comparison
with this reported result, all goats in the current study returned to
normal ejaculation at 9 h post injection and the semen volume was
restored to approximately normal (Ritar et al., 1992) within 6 h post
injection. This suggested that the goats had partially recovered
from suppressed ejaculation at 6 h after TAM injection and this
effect had not persisted for more than 9 h post injection.
Regarding semen quality, the semen volume and number of
spermatozoa increased with time after TAM treatment. This result
related to the gradual recovery from the TAM ejaculatory sup-
pression effect. Noteworthy, was that the number of live sperma-
tozoa at 9 h was more varied than at 1 h post injection. This may
have been due to the effect of alpha1 adrenoceptor antagonist on
changing the epididymal environment which requires testing in
further studies.
The heart rate suddenly increased and was highest at 1 h post
TAM injection. According to previous study, the heart rate at 3 h
post TAM injection tended to be higher than before injection in
goats (Kimsakulvech et al., 2014). In dogs, TAM at 3 mg/kg intra-
venous administration could decrease the mean arterial blood
pressure within 30 min by about 10 mmHg (Ohtake et al., 2004).
Alpha1 adrenoceptor antagonist has been reported to decrease
blood pressure through relaxing smoothmuscle. However, TAM has
been developed to further improve the efﬁcacy:safety ratio with a
lower incidence of cardiovascular system problems through the use
of a vasodilator (Ohtake et al., 2004; Michel et al., 2005a; Michel
and Chapple, 2006; Kobayashi et al., 2009). In the present study,
TAM 80 mg/kg show no distinct evidence of a decrease in blood
pressure or heart rate; nevertheless, this may depend on the
dosage, effect duration or animal species.
The present study clearly showed that TAM could suppress
ejaculation within 1 h post injection in goat and the effect was
maintained for up to 3 h post injection. Recovery occurred within
9 h post injection without changing sexual desire and copulation.
Tamsulosin may have different effects on different animal species.
This study in goats is a model of the use of alpha1 adrenoceptor
antagonist on the suppression of ejaculation and can be applied to
other species. Many types of alpha1 adrenoceptor antagonists may
possess more advantages for the suppression of ejaculation. In
further studies, other types of alpha1 adrenoceptor antagonist
should be compared and examined.injection.
zoa concentration
s)
Numbers of spermatozoa
(109 cells)
Live
spermatozoa (%)
ALP (104
IU*)
8 1.45 ± 0.45 65.50 ± 17.00 5.24 ± 3.57
9 0.80 ± 0.22 40.75 ± 17.01 6.51 ± 1.70
8 1.88 ± 0.21 25.68 ± 8.35 5.12 ± 1.11
4 2.89 ± 0.50 26.85 ± 4.07 5.44 ± 0.94
1 0.88 ± 0.29a 41.83 ± 24.00 4.96 ± 1.25
3 2.05 ± 0.12b 17.00 ± 3.50 6.83 ± 2.18
0 2.29 ± 0.32ab 29.00 ± 5.85 5.37 ± 1.77
ent at p < 0.05.
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